Epigenic Therapeutics

Developer of gene editing therapies for a wide variety of diseases

placeShanghai, Shanghai, China calendar_todayFounded 2021 language epigenictx.com

Innovation

24 patent families — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace accelerating. Cited 480 times.

YearFilings
20236
202414
202514
20264

Social engagement

Social engagement: 608 social following, 6 posts in the last 12 months — below the industry typical range.

Investor mix

8 investors on record; lead investors include Qiming Venture Partners, Orbimed, Lapam Capital.

Investor typeCountShare
Venture capital675%
Other / undisclosed225%

Recent activity

3 Mar 2026
Leadership hire
Chief Medical Officer
15 Jan 2026
Milestone
regulatory
19 Dec 2025
Milestone
regulatory
Coming soon